Skip to search formSkip to main contentSkip to account menu

BMS 181339

Known as: BMS-181339 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A Phase II study of paclitaxel in patients with primary advanced or metastatic breast cancer was conducted by a cooperative study… 
1997
1997
Paclitaxel (BMS‐181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of… 
1996
1996
A phase II study of Paclitaxel in patients with ovarian cancer by 3-hour intravenous infusion was undertaken by a cooperative… 
Review
1996
Review
1996
We conducted a multi-institutional (11 facilities), early phase II study of BMS-181339 (paclitaxel), a novel anti-cancer drug… 
1994
1994
We conducted a multicenter Phase II study of BMS-181339 in patients with ovarian cancer. The facilities participating were 23 in…